Finally, in the PFS analysis, MZF1 was found to be a risk factor in STAD, LGG, LUSC, and PRAD, while it functioned as a protective factor in ACC, BLCA, OV, THCA, PCPG, SARC, and TGCT patients (Figure 4D). The gene discussed is MZF1; the disease is adrenal cortex carcinoma.